Long-term safety and efficacy outcomes of the Acellular Tissue Engineered Vessel (ATEV) in extremity arterial trauma repair
Symvess use for arterial reconstruction in setting of limb threatening arterial injury is associated with low infection rates, and acceptable limb salvage outcomes over 36 months in a high-risk trauma population when use of saphenous vein was not feasible. These results suggest Symvess represents a new alternative when autologous vein is not feasible for arterial reconstruction in extremity trauma.
Authors
- Ying Wei Lum (ORCID: https://orcid.org/0000-0001-9312-4448)
- Shamik Parikh (ORCID: https://orcid.org/0009-0001-2380-439X)
- Zakaria Khondker
- Miguel Berdugo (ORCID: https://orcid.org/0000-0003-1053-8907)
- Charles J. Fox (ORCID: https://orcid.org/0000-0002-5393-3926)
- Ernest Eugene Moore (ORCID: https://orcid.org/0000-0002-0419-4848)
- Michael A. Curi (ORCID: https://orcid.org/0000-0002-3605-0910)
- Ilya Goldin
- Nicholas Namias (ORCID: https://orcid.org/0000-0001-7021-2250)
- Rishi Kundi (ORCID: https://orcid.org/0000-0001-8644-999X)
- Laura E. Niklason (ORCID: https://orcid.org/0000-0002-5156-504X)
- Sophia Bou-Ghannam
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Maryland, Baltimore (US)
- University of Maryland Medical Center (US)
- Johns Hopkins University (US)
- Shaare Zedek Medical Center (IL)
- Denver Health Medical Center (US)
- Johns Hopkins Bayview Medical Center (US)
- Jackson Memorial Hospital (US)
- Humacyte (United States) (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of Vascular Surgery Cases and Innovative Techniques
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.jvscit.2025.102042
- Primary Topic
- Infectious Aortic and Vascular Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00